Human cytomegalovirus-inhibitory flavonoids: Studies on antiviral activity and mechanism of action

Antiviral Research

Volumn 68, Issue 3, 2005, Pages 124-134

  Evers, David L ^a   Chao, Chih Fang ^a   Wang, Xin ^a   Zhang, Zhigang ^a   Huong, Shu Mei ^a   Huang, Eng Shang ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral; Baicalein; Cytomegalovirus; Entry; Genistein; Immediate early function

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANTIVIRUS AGENT; APIGENIN; BAICALEIN; BIOCHANIN A; DAIDZEIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; FLAVONOID; FLAVONOL; GALANGIN; GANCICLOVIR; GENISTEIN; IMMEDIATE EARLY PROTEIN; ISOFLAVONE; LUTEOLIN; NARINGENIN; QUERCETIN; VIRUS DNA; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CYTOTOXICITY; DNA SYNTHESIS; DRUG ACTIVITY; ENZYME ACTIVITY; HOST CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; VIRUS PARTICLE; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL CULTURE TECHNIQUES; CYTOMEGALOVIRUS; FLAVONOIDS; HUMANS; IMMEDIATE-EARLY PROTEINS; VIRUS REPLICATION;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 27744472231     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2005.08.002     Document Type: Article

References (52)

1. H. Adlercreutz, H. Markkanen, and S. Watanabe Plasma concentrations of phyto-oestrogens in Japanese men Lancet 342 1993 1209 1210
2. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami Genistein, a specific inhibitor of tyrosine-specific protein kinases J. Biol. Chem. 262 1987 5592 5595
3. S.M. Akula, D.J. Hurley, R.L. Wixon, C. Wang, and C.C. Chase Effect of genistein on replication of bovine herpesvirus type 1 Am. J. Vet. Res. 63 2002 1124 1128
4. C.A. Alford, and W.J. Britt B. Roizman R.J. Whitley C. Lopez The Human Herpesviruses 1993 Raven Press New York 227 255
5. M. Amoros, C.M. Simoes, L. Girre, F. Sauvager, and M. Cormier Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis J. Nat. Prod. 55 1992 1732 1740
6. J. Barnes Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality Br. J. Clin. Pharmacol. 55 2003 226 233
7. J. Barnes Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety Br. J. Clin. Pharmacol. 55 2003 331 340
8. G.R. Beecher Overview of dietary flavonoids: nomenclature, occurrence and intake J. Nutr. 133 2003 3248S 3254S
9. J.P. Castillo, A.D. Yurochko, and T.F. Kowalik Role of human cytomegalovirus immediate-early proteins in cell growth control J. Virol. 74 2000 8028 8037
10. J.M. Cherrington, and E.S. Mocarski Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element J. Virol. 63 1989 1435 1440
11. L.C. Chiang, W. Chiang, M.C. Liu, and C.C. Lin In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids J. Antimicrob. Chemother. 52 2003 194 198
12. H. Cho, M. Ueda, M. Tamaoka, M. Hamaguchi, K. Aisaka, Y. Kiso, T. Inoue, R. Ogino, T. Tatsuoka, and T. Ishihara Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase J. Med. Chem. 34 1991 1503 1505
13. M.G. Davis, S.C. Kenney, J. Kamine, J.S. Pagano, and E.S. Huang Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus Proc. Natl. Acad. Sci. U.S.A. 84 1987 8642 8946
14. D. Dittmer, and E.S. Mocarski Human cytomegalovirus infection inhibits G1/S transition J. Virol. 71 1997 1629 1634
15. D.L. Evers, X. Wang, and E.S. Huang Cellular stress and signal transduction responses to human cytomegalovirus infection Microbes Infect 6 2004 1084 1093
16. J.V. Formica, and W. Regelson Review of the biology of Quercetin and related bioflavonoids Food Chem. Toxicol. 33 1995 1061 1080
17. M. Gabor Anti-inflammatory and anti-allergic properties of flavonoids Prog. Clin. Biol. Res. 213 1986 471 480
18. C.A. Gleaves, D.A. Hursh, D.H. Rice, and J.D. Meyers Detection of cytomegalovirus from clinical specimens in centrifugation culture by in situ DNA hybridization and monoclonal antibody staining J. Clin. Microbiol. 27 1989 21 23
19. P.D. Griffiths The 2001 Garrod lecture. The treatment of cytomegalovirus infection J. Antimicrob. Chemother. 49 2002 243 253
20. K. Hayashi, T. Hayashi, H. Otsuka, and Y. Takeda Antiviral activity of 5,6,7-trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir J. Antimicrob. Chemother. 39 1997 821 824
21. Y.S. He, L. Xu, and E.S. Huang Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product J. Virol. 66 1992 1098 1108
22. P.J. Hippenmeyer, and V.M. Dilworth A rapid assay for determination of antiviral activity against human cytomegalovirus Antiviral Res. 32 1996 35 42
23. W.Z. Ho, R. Cherukuri, S.D. Ge, J.R. Cutilli, L. Song, S. Whitko, and S.D. Douglas Centrifugal enhancement of human immunodeficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitro J. Leukoc. Biol. 53 1993 208 212
24. E.S. Huang, S.T. Chen, and J.S. Pagano Human cytomegalovirus. I. Purification and characterization of viral DNA J. Virol. 12 1973 1473 1481
25. F.M. Jault, J.M. Jault, F. Ruchti, E.A. Fortunato, C. Clark, J. Corbeil, D.D. Richman, and D.H. Spector Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest J. Virol. 69 1995 6697 6704
26. R.A. Johnson, S.M. Huong, and E.S. Huang Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H - imidazole on HCMV DNA replication and permissive infection Antiviral Res. 41 1999 101 111
27. T.F. Kowalik, A.D. Yurochko, C.A. Rinehart, C.Y. Lee, and E.S. Huang Productive infection of human endometrial stromal cells by human cytomegalovirus Virology 202 1994 247 257
28. S. Landolfo, M. Gariglio, G. Gribaudo, and D. Lembo The human cytomegalovirus Pharmacol. Ther. 98 2003 269 297
29. Y.M. Lin, M.T. Flavin, R. Schure, F.C. Chen, R. Sidwell, D.L. Barnard, J.H. Huffman, and E.R. Kern Antiviral activities of biflavonoids Planta Med. 65 1999 120 125
30. E.C. Mar, Y.C. Cheng, and E.S. Huang Effect of 9-(1,3-dihydroxy-2- propoxymethyl)guanine on human cytomegalovirus replication in vitro Antimicrob. Agents Chemother. 24 1983 518 521
31. E. Middleton Jr., C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol. Rev. 52 2000 673 751
32. D. Mitrocotsa, S. Mitaku, S. Axarlis, C. Harvala, and M. Malamas Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus Planta Med. 66 2000 377 379
33. P. Muganda, O. Mendoza, J. Hernandez, and Q. Qian Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts J. Virol. 68 1994 8028 8034
34. S. Pajovic, E.L. Wong, A.R. Black, and J.C. Azizkhan Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins Mol. Cell Biol. 17 1997 6459 6464
35. M.N. Prichard, S.R. Turk, L.A. Coleman, S.L. Engelhardt, C. Shipman Jr., and J.C. Drach A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus J. Virol. Methods 28 1990 101 106
36. V. Robin, A. Irurzun, M. Amoros, J. Boustie, and L. Carrasco Antipoliovirus flavonoids from Psiadia dentata Antivir. Chem. Chemother. 12 2001 283 291
37. L.C. Sambucetti, J.M. Cherrington, G.W. Wilkinson, and E.S. Mocarski NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation EMBO J. 8 1989 4251 4258
38. K. Sekiya, and H. Okuda Selective inhibition of platelet lipoxygenase by baicalein Biochem. Biophys. Res. Commun. 105 1982 1090 1095
39. R.K. Seth, M.S. Haque, and P.S. Zelenka Regulation of c-fos induction in lens epithelial cells by 12(S)HETE-dependent activation of PKC Invest Ophthalmol. Vis. Sci. 42 2001 3239 3246
40. M.E. Slobbe-van Drunen, R.C. Vossen, F.M. Couwenberg, M.M. Hulsbosch, J.W. Heemskerk, M.C. van Dam-Mieras, and C.A. Bruggeman Activation of protein kinase C enhances the infection of endothelial cells by human cytomegalovirus Virus Res. 48 1997 207 213
41. R.R. Spaete, and E.S. Mocarski Insertion and deletion mutagenesis of the human cytomegalovirus genome Proc. Natl. Acad. Sci. U.S.A. 84 1987 7213 7217
42. E. Speir, R. Modali, E.S. Huang, M.B. Leon, F. Shawl, T. Finkel, and S.E. Epstein Potential role of human cytomegalovirus and p53 interaction in coronary restenosis Science 265 1994 391 394
43. B.W. van der Strate, F.M. De Boer, H.I. Bakker, D.K. Meijer, G. Molema, and M.C. Harmsen Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro Antiviral Res. 58 2003 159 165
44. X. Wang, S.M. Huong, M.L. Chiu, N. Raab-Traub, and E.S. Huang Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus Nature 424 2003 456 461
45. F. Wei, S.C. Ma, L.Y. Ma, P.P. But, R.C. Lin, and I.A. Khan Antiviral flavonoids from the seeds of Aesculus chinensis J. Nat. Prod. 67 2004 650 653
46. O.S. Weislow, R. Kiser, D.L. Fine, J. Bader, R.H. Shoemaker, and M.R. Boyd New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity J. Natl. Cancer Inst. 81 1989 577 586
47. L. Wiebusch, and C. Hagemeier Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1) J. Virol. 73 1999 9274 9283
48. B.A. Wing, G.C. Lee, and E.S. Huang The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics J. Virol. 70 1996 3339 3345
49. L. Yi, Z. Li, K. Yuan, X. Qu, J. Chen, G. Wang, H. Zhang, H. Luo, L. Zhu, P. Jiang, L. Chen, Y. Shen, M. Luo, G. Zuo, J. Hu, D. Duan, Y. Nie, X. Shi, W. Wang, Y. Han, T. Li, Y. Liu, M. Ding, H. Deng, and X. Xu Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells J. Virol. 78 2004 11334 11339
50. A.D. Yurochko, E.S. Hwang, L. Rasmussen, S. Keay, L. Pereira, and E.S. Huang The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection J. Virol. 71 1997 5051 5059
51. A.D. Yurochko, T.F. Kowalik, S.M. Huong, and E.S. Huang Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters J. Virol. 69 1995 5391 5400
52. A.D. Yurochko, M.W. Mayo, E.E. Poma, A.S. Baldwin Jr., and E.S. Huang Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters J. Virol. 71 1997 4638 4648